Cardiovascular disease disparities: Racial/ethnic factors and potential solutions

Current Cardiovascular Risk Reports

Volumn 3, Issue 3, 2009, Pages 187-193

  Ferdinand, Keith C ^a   Ferdinand, Daphne P ^b  

^a Association of Black Cardiologists   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952540468     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0030-y     Document Type: Article

References (51)

1. US Department of State: U. S. Minorities Will Be the Majority by 2042, Census Bureau Says. Available at http://www. america. gov/st/diversity-english/2008/August/20080815140005xlrennef0. 1078106. html. Accessed March 12, 2009.
2. US Census Bureau: Population Projections: U. S. Interim Projections by Age, Sex, Race, and Hispanic Origin: 2000-2050. Available at http://www. census. gov/population/www/projections/usinterimproj. Accessed March 12, 2009.
3. Manchester J, Topoleski J: Growing Disparities in Life Expectancy. Economic and Budget Issue Brief. A Series of Issue Summaries from the Congressional Budget Office. Washington, DC: Congress of the United States; Congressional Budget Office; 2008.
4. Miniño, AM, Heron MP, Smith BL: Deaths: preliminary data for 2004. Natl Vital Stat Rep 2006, 54: 1-49.
5. US Census Bureau: The Face of Our Population. Available at http://factfinder. census. gov/jsp/saff/SAFFInfo. jsp?_pageId=tp9_race_ethnicity. Accessed March 12, 2009.
6. Bahrami H, Kronmal R, Bluemke DA, et al.: Differences in the incidence of congestive heart failure by ethnicity the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008, 168: 2138-2145.
7. Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119: 480-486.
8. Victor RG, Leonard D, Hess P, et al.: Factors associated with hypertension awareness, treatment, and control in Dallas County, Texas. Arch Intern Med 2008, 168: 1285-1293.
9. Douglas JG, Bakris GL, Epstein M, et al.: Management of the high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003, 163: 525-534.
10. Morales LS, Elliott M, Weech-Maldonado R, Hays RD: The impact of interpreters on parents' experiences with ambulatory care for their children. Med Care Res Rev 2006, 63: 110-128.
11. Enas EA, Mohan V, Deepa M, et al.: The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007, 2: 267-275.
12. Russell M, de Simone G, Resnick HE, Howard BV: The metabolic syndrome in American Indians: the Strong Heart Study. J Cardiometab Syndr 2007, 2: 283-287.
13. Green AR, Carney DR, Pallin DJ, et al.: Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med 2007, 22: 1231-1238.
14. Johnson JA: Ethnic differences in cardiovascular drug response. Potential contribution of pharmacogenetics. Circulation 2008, 118: 1383-1393.
15. US Food and Drug Administration; Center for Drug Evaluation and Research: Coumadin labeling. New Labeling Information for Warfarin (marketed as Coumadin). Available at http://www. fda. gov/cder/drug/infopage/warfarin/default. htm. Accessed March 12, 2009.
16. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.
17. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al.: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003, 290: 2805-2816.
18. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359: 995-1003.
19. US Food and Drug Administration; Center for Drug Evaluation and Research: Cozaar labeling. Available at http://www. fda. gov/cder/foi/label/2001/20386s26lbl. pdf. Accessed March 12, 2009.
20. Calhoun DA, Jones D, Textor S, et al.: Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008, 51: 1403-1419.
21. Wright JT, Bakris G, Green T, et al.: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK Trial. JAMA 2002, 288: 2421-2431.
22. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E: C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001, 37: 739-743.
23. Sehgal AR. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension 2004, 43: 566-572.
24. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289: 2560-2672.
25. Beta-Blocker Evaluation of Survival Trial Investigators: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001, 344: 1659-1667.
26. Dries DL, Exner DV, Gersh BJ, et al.: Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999, 340: 609-616.
27. Ferdinand KC: Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?J Law Med Ethics 2008, 36: 458-463.
28. Taylor AL, Ziesche S, Yancy C: Combination of isosorbide dinitrate in blacks with heart failure. N Engl J Med 2004, 351: 2049-2057.
29. McNamara DM, Tam SW, Sabolinski ML, et al.: G protein beta 3 subunit (GNB3) genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: fesults of the A-HeFT Trial [abstract 2174]. Circulation 2006, 114: II-442.
30. Fiscella K, Tancredi D: Socioeconomic status and coronary heart disease risk prediction. JAMA 2008, 300: 2666-2668.
31. Centers for Disease Control and Prevention (CDC): Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke-United States, 2003. MMWR Morb Mortal Wkly Rep 2005, 54: 113-117.
32. Foraker RE, Rose KM, McGinn AP, et al.: Neighborhood income, health insurance, and prehospital delay for myocardial infarction: the Atherosclerosis Risk in Communities Study. Arch Intern Med 2008, 168: 1874-1879.
33. Mitchell R, Popham F: Effect of exposure to natural environment on health inequalities: an observational population study. Lancet 2008, 372: 1655-1660.
34. Kivimäki M, Shipley MJ, Ferrie JE, et al.: Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet 2008, 372: 1648-1654.
35. Agency for Healthcare Research and Quality: 2007 National Healthcare Quality Report. Rockville, MD: US Department of Health and Human Services; Agency for Healthcare Research and Quality; 2008. [AHRQ publication no. 08-0040.].
36. Agency for Healthcare Research and Quality: 2007 National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services; Agency for Healthcare Research and Quality; 2008. [AHRQ publication no. 08-0041.].
37. Centers for Disease Control and Prevention (CDC): Cigarette smoking among adults-United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57: 1221-1226.
38. Alexander GC, Sehgal NL, Moloney RM, Stafford RS: National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008, 168: 2088-2094.
39. Rhee MK, Ziemer DC, Caudle J, et al.: Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ 2008, 34: 655-663.
40. US Department of Health and Human Services: Eliminating Health Disparities: Strengthening Data on Race, Ethnicity, and Primary Language in the United States. Available at http://www. cdc. gov/nchs/data/misc/EliHealthDisp. pdf. Accessed March 12, 2009.
41. Ix JH, Allison MA, Deneberg JO, et al.: Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol 2008, 51: 2347-2354.
42. Sequist TD, Fitzmaurice GM, Marshall R, et al.: Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med 2008, 168: 1145-1151.
43. Jacoby MB, Sullivan TA, Warren E: Medical problems and bankruptcy filings. Norton's Bankruptcy Law Adviser. May 2000. Cited in: Institute of Medicine, Committee on the Consequences of Uninsurance: Insuring America's Health: Principles and Recommendations. Washington, DC: National Academy Press; 2004.
44. Kaisernetwork. org: Kaiser Health Disparities Report: A Weekly Look at Race, Ethnicity and Health. Available at http://www. kaisernetwork. org/DAILY_REPORTS/rep_index. cfm?DR_ID=54193. Accessed March 12, 2009.
45. US Department of Health and Human Services: Healthy People 2010. Leading Health Indicators. Available at http://www. healthypeople. gov/LHI. Accessed March 12, 2009.
46. Nielsen-Bohlman L, Panzer AM, Kindid DA: Health Literacy: A Prescription to End Confusion. Washington, DC: National Academy Press; 2004.
47. US Department of Health and Human Services; Office of Minority Health: Think Cultural Health: Bridging the Health Care Gap Through Cultural Competency Continuing Education Programs. Available at http://www. thinkculturalhealth. org/. Accessed March 12, 2009.
48. Francis CK, Alpert JS, Clark LT, et al.: Working group 3: how to encourage more minorities to choose a career in cardiology. J Am Coll Cardiol 2004, 44: 241-245.
49. Hayes B: Increasing the representation of underrepresented minority groups in US colleges and schools of pharmacy. Am J Pharm Educ 2008, 72: 14.
50. Saha S, Guiton G, Wimmers PF, Wilkerson L: Student body racial and ethnic composition and diversity-related outcomes in US medical schools. JAMA 2008, 300: 1135-1145.
51. Institute of Medicine Committee on Quality of Health Care in America: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington DC: National Academy Press; 2001.